Browsing Tag
Normal
1 post
Rivian (RIVN) falls 18% as $1.2bn share sale tests R2 funding case
Rivian fell 18% after pricing a 75m share sale at US$15.50. July results must prove R2 demand can outrun dilution and cash burn.